Apimeds Pharmaceuticals US, Inc.
APUS
$1.75
-$0.06-3.32%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.50K | 26.60K | 63.30K | 147.40K | 410.50K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.60K | 10.30K | -- | 10.30K | 11.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 10.30K | -- | -- |
| Total Current Assets | 13.10K | 36.90K | 73.70K | 157.70K | 422.10K |
|
|
|||||
| Total Current Assets | 13.10K | 36.90K | 73.70K | 157.70K | 422.10K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 13.10K | 36.90K | 73.70K | 157.70K | 422.10K |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 697.80K | 508.80K | 387.40K | 135.50K | 123.30K |
| Short-term Debt | 326.50K | 250.00K | 100.00K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 2.60K | 800.00 | 1.00K | -- |
| Total Other Current Liabilities | -- | 2.60K | 800.00 | 1.00K | -- |
| Total Current Liabilities | 1.02M | 761.40K | 488.20K | 136.50K | 123.30K |
|
|
|||||
| Total Current Liabilities | 1.02M | 761.40K | 488.20K | 136.50K | 123.30K |
| Long-Term Debt | 346.80K | 322.00K | 299.50K | 285.80K | 266.90K |
| Short-term Debt | 326.50K | 250.00K | 100.00K | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.37M | 1.08M | 787.60K | 422.30K | 390.20K |
|
|
|||||
| Common Stock & APIC | 3.03M | 3.03M | 3.03M | 3.03M | 3.03M |
| Retained Earnings | -4.39M | -4.08M | -3.75M | -3.30M | -3.00M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1.36M | -1.05M | -714.00K | -264.60K | 31.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.36M | -1.05M | -714.00K | -264.60K | 31.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.36M | -1.05M | -714.00K | -264.60K | 31.90K |
|
|
|||||